Use of riluzole or its salts for preventing and treating adrenoleukodystrophy

Details for Australian Patent Application No. 2001274195 (hide)

Owner Aventis Pharma S.A. Institut National De La Sante Et De La Recherche Medicale

Inventors Stutzmann, Jean-Marie; Aubourg, Patrick; Dib, Michel

Agent Davies Collison Cave

Pub. Number AU-B-2001274195

PCT Pub. Number WO01/93802

Priority 00 07162 05.06.00 FR

Filing date 5 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 1 December 2005

International Classifications

A61P 003/00 Drugs for disorders of the metabolism

A61K 031/425 - Thiazoles

Event Publications

1 December 2005 Application Accepted

  Published as AU-B-2001274195

30 March 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001274196

2001274193